Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National uniformity provision not included in Senate FDA reform legislation.

This article was originally published in The Tan Sheet

Executive Summary

NATIONAL UNIFORMITY LANGUAGE NOT INCLUDED IN SENATE FDA REFORM LEGISLATION as introduced by Labor & Human Resources Committee Chairman James Jeffords (R-Vt.) on June 5. The provision, which would allow FDA regulations to transcend local and state governments' safety and labeling regs for over-the-counter drugs, cosmetics and foods, was expected to be included in the first draft of S 830. At a May 28 press briefing, the committee had noted that although specific national uniformity language was not yet written, the measure was still of high interest and was under development ("The Tan Sheet" June 2, p. 1).
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087159

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel